At eGenesis, we are committed to ending the global transplant shortage and transforming the treatment of organ failure. We are bringing that vision closer to reality with lead programs in kidney and islet cell transplantation.
Read More: eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant
At eGenesis, we are committed to ending the global transplant shortage and transforming the treatment of organ failure. We are bringing that vision closer to reality with lead programs in kidney and islet cell transplantation.
